Apr 21
Alteogen's Hybrozyme: Korean Subcutaneous Drug Delivery Tech Explained
💡 Quick Take: Alteogen’s Hybrozyme technology is revolutionizing drug administration by converting complex intravenous biologics into simpler, more patient-friendly subcutaneous injections, significantly enhancing global healthcare access. 1. The Big Picture: Why This Matters Now 1.1. Global Context The global biologics market was estimated at approximately $400 billion as of 2025, with…